CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L306. A total of 23 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,000 | -63.6% | 10,059 | -54.6% | 0.00% | – |
| Q3 2015 | $11,000 | -56.0% | 22,167 | -29.3% | 0.00% | – |
| Q2 2015 | $25,000 | -62.1% | 31,345 | -66.6% | 0.00% | -100.0% |
| Q4 2014 | $66,000 | -29.0% | 93,981 | +204.1% | 0.00% | -50.0% |
| Q3 2014 | $93,000 | +121.4% | 30,906 | +128.4% | 0.00% | +100.0% |
| Q2 2014 | $42,000 | -72.5% | 13,531 | -64.6% | 0.00% | -50.0% |
| Q4 2013 | $153,000 | +118.6% | 38,241 | +133.1% | 0.00% | +100.0% |
| Q3 2013 | $70,000 | – | 16,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,632,259 | $628,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 17,500 | $7,000 | 0.00% |
| CONDOR CAPITAL MANAGEMENT | 10,000 | $4,000 | 0.00% |
| NORTHERN TRUST CORP | 33,166 | $13,000 | 0.00% |
| UBS Group AG | 2,227 | $1,000 | 0.00% |
| CITIGROUP INC | 30 | $0 | 0.00% |
| Krilogy Financial LLC | 600 | $1,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 106,036 | $41,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 86,456 | $33,000 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 24,900 | $9,000 | 0.00% |